Characterizing Skin Cancers Arising for the First Time Following Solid Organ Transplant with Subsequent Recurrence
Main Article Content
Keywords
Transplant, Immunosuppression, Skin cancer
Abstract
Introduction: There is an established relationship between solid organ transplantation (SOT) and increased incidence of skin cancers. There is a paucity of data characterizing skin cancers arising for the first-time post-transplant that subsequently recur.
Methods: We conducted a retrospective review to identify SOT recipients (SOTRs) at our institution with recurrence of skin cancer that initially developed post-transplant (“recurrence”). Patients with pre-transplant history of skin cancer were excluded. Data was analyzed using one-sample t-tests.
Results: Of 530 SOTRs identified, 33 had recurrence (mean 3.97 + 6.97). SOTRs with recurrence were male (87.9%), white (97%), kidney recipients (75.7%) with a mean age at transplant of 56.52 [+11.69] years (p-value<0.001 each). Recurrences arose from SCC (66.7%) on the face or scalp (57.5%), which were invasive at time of diagnosis (63.6%) (p-value<0.001 each).
Conclusion: White kidney and cardiac SOTRs have high risk for recurrence and thus should have annual examinations performed by a dermatologist.
References
2. Moyal DD, Fourtanier AM. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings. J Am Acad Dermatol. 2008;58(5 Suppl 2):S149-154.
3. Nindl I, Rösl F. Molecular concepts of virus infections causing skin cancer in organ transplant recipients. Am J Transplant. 2008;8(11):2199-2204.
4. O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65(2):253-261.
5. Baldwin S, Au S. One-Year Review of the SCREEN (Skin Cancer Post-Transplant) Clinic. J Cutan Med Surg. 2017;21(1):80-81.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.